Abstract: Methods of analyzing non-clinical parameters, methods of analyzing clinical parameters, methods of producing visual images, systems of analyzing non-clinical parameters, systems of analyzing clinical parameters, systems of producing visual images, systems of producing reports, reports based on imaging modality information, and displays based on imaging modality information, are disclosed.

Abstract: Refractory delay circuitry ensures that induced currents do not falsely rigger the acquisition phase of magnetic-resonance instrumentation. Immediately after the triggering of the acquisition sequence, for example, by the R-wave of a subject's cardiac cycle, the adjustable delay circuit is used to inhibit further trigger signals for a predetermined duration of the acquisition gradient activity. The acquisition sequence will thus not be triggered by extra peaks in the biological signal, which may take the form of non-R-wave signals in the cardiac cycle. In this embodiment of the invention triggering will occur only at most once per heartbeat. As cardiac signals may be divided into two major groups, electrical (ECG) and non-electrical (e.g.

Abstract: The present invention relates to water-soluble, lipophilic contrast-enhancing agents, pharmaceutical compositions thereof and methods for diagnostic analysis, particularly NMR or MRI analysis using these contrast-enhancing agents. The water-soluble, lipophilic contrast-enhancing agents are chelates of a paramagnetic, ferromagnetic or diamagnetic metal ion(s) complexed with completing acids which contain at least one short-chain fatty acyl moiety having from about 0 to about 6 carbon atoms in its structure.

Abstract: The present invention relates to contrast enhancing agents, conjugates thereof, pharmaceutical compositions thereof, and methods for diagnostic analysis, particularly NMR image analysis using these agents. The contrast enhancing agents are chelates of paramagnetic, ferromagnetic or diamagnetic metal ion(s) complexed with new lipophilic complexing acids related to polyaminopolycarboxylic acids.

Abstract: The present invention relates to contrast enhancing agents, conjugates thereof, pharmaceutical compositions thereof, and methods for diagnostic analysis, particularly NMR image analysis using these agents. The contrast enhancing agents are chelates of paramagnetic, ferromagnetic or diamagnetic metal ion(s) complexed with new lipophilic complexing acids related to polyaminopolycarboxylic acids.

Abstract: The present invention relates to contrast enhancing agents, conjugates thereof, pharmaceutical compositions thereof, and methods for diagnostic analysis, particularly NMR image analysis using these agents. The contrast enhancing agents are chelates of paramagnetic, ferromagnetic or diamagnetic metal ion(s) complexed with new lipophilic complexing acids related to polyaminopolycarboxylic acids.

Abstract: The present invention relates to contrast enhancing agents, conjugates thereof, pharmaceutical compositions thereof, and methods for diagnostic analysis, particularly NMR image analysis using these agents. The contrast enhancing agents are chelates of paramagnetic, ferromagnetic or diamagnetic metal ion(s) complexed with new lipophilic complexing acids related to polyaminopolycarboxylic acids.

Abstract: The present invention relates to a class of compositions and a method for NMR imaging using an NMR signal affecting amount of a paramagnetic, diamagnetic or ferromagnetic metal ion chelated with an organo phosphorous compound.Gadolinium bis(bis-dihydroxyphosphonylmethylphosphinate) is an example of such a composition.